Numerickaya, K. and Riss , M. 2022. Prospects of using the genetically engineered preparation dupilumab for the treatment of atopic dermatitis in the adult population. Journal of Pakistan Association of Dermatologists. 32, 2 (Jun. 2022), 327–333.